{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:06:09Z","timestamp":1759017969832,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.annder.2021.07.012","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:40:44Z","timestamp":1655772044000},"page":"195-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Infliximab treatment before and after surgery in severe hidradenitis suppurativa: A retrospective study of 10 patients"],"prefix":"10.1016","volume":"149","author":[{"given":"E.","family":"Benassaia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chaouat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bachelez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-D.","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.07.012_bib0065","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis Suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2021.07.012_bib0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.annder.2021.07.012_bib0075","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2021.07.012_bib0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2021.07.012_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.07.012_bib0090","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jaad.2015.07.044","article-title":"Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis","volume":"73","author":"Mehdizadeh","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.07.012_bib0095","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jdv.15706","article-title":"Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidenitis suppurativa patients: a prospective single center study","volume":"33","author":"Prens","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.07.012_bib0100","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/DSS.0000000000000806","article-title":"Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients","volume":"42","author":"Kohorst","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.annder.2021.07.012_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SAP.0000000000000584","article-title":"Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa","volume":"77","author":"DeFazio","year":"2016","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.annder.2021.07.012_bib0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.10807.x","article-title":"Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions: Match","volume":"167","author":"Van Rappard","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.07.012_bib0115","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.18003","article-title":"PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens","volume":"181","author":"Gottlieb","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.07.012_bib0120","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jaad.2020.06.042","article-title":"Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa","volume":"83","author":"Bettuzzi","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:29Z","timestamp":1758971429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0151963821000971"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.07.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab treatment before and after surgery in severe hidradenitis suppurativa: A retrospective study of 10 patients","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}